|1.||Yang, Yumin: 6 articles (06/2014 - 01/2011)|
|2.||Yan, Tianhua: 5 articles (12/2015 - 04/2015)|
|3.||Zhu, Lingpeng: 5 articles (12/2015 - 04/2015)|
|4.||Ding, Fei: 5 articles (06/2014 - 12/2008)|
|5.||Chang, Xiayun: 4 articles (12/2015 - 09/2015)|
|6.||He, He: 4 articles (12/2015 - 09/2015)|
|7.||Gao, Jin: 4 articles (12/2015 - 09/2015)|
|8.||Zhao, Yahong: 4 articles (04/2013 - 01/2011)|
|9.||Luo, Fen: 3 articles (11/2015 - 09/2015)|
|10.||Wu, Dan: 3 articles (09/2015 - 10/2011)|
07/01/2014 - "Our findings suggest that salidroside has protective effects on chronic intermittent hypoxia-induced Fas-dependent and mitochondria-dependent apoptotic pathways in mice hearts."
08/01/2009 - "Salidroside may represent a novel therapeutic agent for the treatment and prevention of hypoxia and oxidative stress-related diseases."
04/01/2009 - "The present study was aimed to investigate the cardioprotective role of salidroside and the underlying mechanisms in hypoxia-induced cardiomyocyte death. "
10/01/2015 - "We propose a novel mechanism for salidroside-mediated neuroprotection in hypoxia. "
10/01/2015 - "Taken together, these findings suggest a synergistic role of pIRA and SIRT1 in salidroside-mediated neuroprotection, mitochondrial biogenesis, and cognitive improvement during hypoxia. "
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
06/14/2007 - "These results suggest that salidroside has protective effects against oxidative stress-induced cell apoptosis, which might be a potential therapeutic agent for treating or preventing neurodegenerative diseases implicated with oxidative stress."
12/01/2009 - "Perhaps, this study might contribute to the development of salidroside as a broad-spectrum agent for preventing and/or treating neuronal damage in neurodegenerative disorders."
12/01/2008 - "Our findings might raise a possibility of potential therapeutic applications of salidroside for preventing and treating cerebral ischemic and neurodegenerative diseases."
04/01/2013 - "Therefore, our new findings may provide potentially important information for further development of salidroside analogues and lay the basis for further studies on the cerebral ischemic stroke and neurodegenerative diseases for human clinical treatment."
11/01/2010 - "Salidroside inhibited Abeta(25-35)-induced phosphorylation of JNK and p38 MAP kinase, but not ERK1/2. These results suggest that salidroside has protective effects against Abeta(25-35)-induced oxidative stress, which might be a potential therapeutic agent for treating or preventing neurodegenerative diseases."
|3.||Acute Lung Injury
08/01/2012 - "In this study, we investigated protective effects of salidroside on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. "
08/01/2012 - "Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice."
01/01/2014 - "This study was designed to investigate the protective effects of salidroside (SDS) via suppressing the expression of transforming growth factor-β1 (TGF-β1) in rat acute lung injury (ALI) induced by paraquat (PQ) and to explore the potential molecular mechanisms. "
01/01/2014 - "Salidroside alleviates paraquat-induced rat acute lung injury by repressing TGF-β1 expression."
11/01/2010 - "In this study, salidroside (Sald), an active compound isolated from a traditional Chinese medicinal plant, Rhodiola rosea L., was investigated to assess its protective effects and the underlying mechanisms against Abeta-induced oxidative stress in SH-SY5Y human neuroblastoma cells. "
06/14/2007 - "Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells."
11/01/2010 - "Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells."
08/01/2005 - "Human neuroblastoma SH-SY5Y cells were exposed to sodium azide with different concentration of salidroside, then cell viability was measured by thiazolyl blue (MTT) method and mitochondrial membrane potential (MMP) was detected by JC-1 method. "
03/01/2009 - "To study the protective effects of salidroside on oxidative damage in fatigue mice. "
03/01/2009 - "[Protective effects of salidroside on oxidative damage in fatigue mice]."
02/01/2015 - "An ultra-performance liquid chromatography-quadrupole time-of-flight-based metabolomic approach was developed to study influence of salidroside, an anti-fatigue ingredient from Rhoiola rosea, on urinary metabolic profiling of rats to a single dose of 180 mg/kg per day. "
01/01/2012 - "To study the anti-fatigue mechanism of salidroside from Rhodiola SachalinensisA.Bor"
02/01/2015 - "The work showed that metabolomics is a powerful tool in studying the anti-fatigue effects of natural compound salidroside on multiple targets in vivo."
|1.||Hydrogen Peroxide (Hydroperoxide)
|3.||cobaltous chloride (cobalt(II)chloride)
|5.||p38 Mitogen-Activated Protein Kinases
|6.||Reactive Oxygen Species (Oxygen Radicals)
|7.||NF-kappa B (NF-kB)
|8.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|10.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Transplantation (Transplant Recipients)
|3.||Chinese Traditional Medicine (Traditional Chinese Medicine)
|5.||Drug Therapy (Chemotherapy)